Rantum Capital provides subordinated loan to market-leading pharmaceuticals company
Rantum Private Debt Fund III is continuing its investment activity and has today provided a subordinated loan to a market-leading, family-led German pharmaceuticals company. The financing is subordinated behind senior loans provided by a number of German commercial banks. The proceeds will be used for further inorganic growth in the upcoming years. The borrower is family-owned and run by the founder as CEO.
Marc Pahlow, Managing Director of Rantum Capital, commented: “Our borrower has written an impressive success story over the last few years. The new financing with a tailor-made combination of senior bank loans and our subordinated loan paves the way for the continuation of the successful growth path of the company in the upcoming years. Thanks to the unique expertise of our Industrial Partners and from past transactions, Rantum possesses considerable experience in the healthcare sector and we are pleased to complete another investment in this attractive industry.”
Including this transaction, Rantum Private Debt Fund III has deployed approx. one third of its commitment less than a year after first closing. The borrowers are broadly diversified across different sectors and financing situations.